Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CD(Suzhou)Biopharma
Suzhou, Jiangsu, Chinaconnectbiopharm.com ↗
- Ownership
- Private
- Employees
- ~150
- Development stage
- Other
01
Overview
Connect Biopharma is a clinical-stage biopharmaceutical company dedicated to improving the lives of patients with chronic inflammatory diseases through the development of therapies derived from T cell-driven research. The company leverages its expertise in biology and high-throughput screening to identify and advance small molecules and antibodies that modulate critical immune pathways. Its lead program, rademikibart (CBP-201), is a monoclonal antibody targeting IL-4Rα currently in Phase 3 trials for atopic dermatitis. Additionally, the company is developing icanbelimod (CBP-307), an S1P1 receptor modulator for ulcerative colitis, and other early-stage assets targeting GPR15 and IL-33.
- Therapeutic areas
- GastroenterologyPulmonologyDermatologyImmunology
- Modalities
- Monoclonal antibodySmall moleculeBiologic
- Industry
- Biotech
02
Partnerships
Simcere Pharmaceutical Group
Beyond the preview
Go deeper on CD(Suzhou)Biopharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CD(Suzhou)Biopharma.